Sonoma Pharmaceuticals, Inc. (SNOA) Institutional Ownership

Ownership Summary

A total of 5 institutions have reported a stake in Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) as of December 2025, according to recent 13F filings with the SEC.

• Sonoma Pharmaceuticals saw its institutional ownership percentage fell to 1.1% in December 2025 from 3.6% in September 2025.
• The company experienced a -9.94% quarterly change in institutional shares held, alongside a decrease of 50.00% in total owners annually.
• A review of institutional activity for Sonoma Pharmaceuticals shows 0 of 5 filers increasing their positions, while 2 reduced their stake, and 3 remained unchanged.
• The total number of shares held by institutions in Sonoma Pharmaceuticals decreased to 18.92K as of December 2025, a net change of down by 2.09K shares quarter on quarter, and down 1.24K shares year over year.
• As of December 31, 2025, VANGUARD GROUP INC held Sonoma Pharmaceuticals's largest shareholding position with over 18.89K shares, representing 1.14% of total outstanding shares.
• Leading sellers of Sonoma Pharmaceuticals stock in December 2025 included VANGUARD GROUP INC (1.99K), UBS Group AG (102).
• The top 5 institutional holders of Sonoma Pharmaceuticals for the quarter ending December 2025 included VANGUARD GROUP INC (18.89K), US BANCORP \DE\ (25), UBS Group AG (6), Quaker Wealth Management, LLC (3), CWM, LLC (1).